Literature DB >> 27406993

Class 3 semaphorins induce F-actin reorganization in human dendritic cells: Role in cell migration.

Sabrina Curreli1, Bin Sheng Wong2, Olga Latinovic1,3, Konstantinos Konstantopoulos2, Nicholas M Stamatos4,5.   

Abstract

Class 3 semaphorins (Semas) are soluble proteins that are well recognized for their role in guiding axonal migration during neuronal development. In the immune system, Sema3A has been shown to influence murine dendritic cell (DC) migration by signaling through a neuropilin (NRP)-1/plexin-A1 coreceptor axis. Potential roles for class 3 Semas in human DCs have yet to be described. We tested the hypothesis that Sema3A, -3C, and -3F, each with a unique NRP-1 and/or NRP-2 binding specificity, influence human DC migration. In this report, we find that although NRP-1 and NRP-2 are expressed in human immature DCs (imDCs), NRP-2 expression increases as cells mature further, whereas expression of NRP-1 declines dramatically. Elevated levels of RNA encoding plexin-A1 and -A3 are present in both imDCs and mature DC (mDCs), supporting the relevance of Sema/NRP/plexin signaling pathways in these cells. Sema3A, -3C, and -3F bind to human DCs, with Sema3F binding predominantly through NRP-2. The binding of these Semas leads to reorganization of actin filaments at the plasma membrane and increased transwell migration in the absence or presence of chemokine CCL19. Microfluidic chamber assays failed to demonstrate consistent changes in speed of Sema3C-treated DCs, suggesting increased cell deformability as a possible explanation for enhanced transwell migration. Although monocytes express RNA encoding Sema3A, -3C, and -3F, only RNA encoding Sema3C increases robustly during DC differentiation. These data suggest that Sema3A, -3C, and -3F, likely with coreceptors NRP-1, NRP-2, and plexin-A1 and/or -A3, promote migration and possibly other activities of human DCs during innate and adaptive immune responses. © Society for Leukocyte Biology.

Entities:  

Keywords:  chemotaxis; neuropilin-1 and -2; plexins; polysialic acid

Mesh:

Substances:

Year:  2016        PMID: 27406993      PMCID: PMC5109998          DOI: 10.1189/jlb.2A1114-534R

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  45 in total

1.  Unified nomenclature for the semaphorins/collapsins. Semaphorin Nomenclature Committee.

Authors: 
Journal:  Cell       Date:  1999-05-28       Impact factor: 41.582

2.  Semaphorin 3C regulates endothelial cell function by increasing integrin activity.

Authors:  Nazifa Banu; Jason Teichman; Marya Dunlap-Brown; Guillermo Villegas; Alda Tufro
Journal:  FASEB J       Date:  2006-08-29       Impact factor: 5.191

3.  Polysialic acid on neuropilin-2 is exclusively synthesized by the polysialyltransferase ST8SiaIV and attached to mucin-type o-glycans located between the b2 and c domain.

Authors:  Manuela Rollenhagen; Falk F R Buettner; Marc Reismann; Adan Chari Jirmo; Melanie Grove; Georg M N Behrens; Rita Gerardy-Schahn; Franz-Georg Hanisch; Martina Mühlenhoff
Journal:  J Biol Chem       Date:  2013-06-25       Impact factor: 5.157

Review 4.  Immunological functions of the neuropilins and plexins as receptors for semaphorins.

Authors:  Atsushi Kumanogoh; Hitoshi Kikutani
Journal:  Nat Rev Immunol       Date:  2013-11       Impact factor: 53.106

5.  Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates.

Authors:  L Tamagnone; S Artigiani; H Chen; Z He; G I Ming; H Song; A Chedotal; M L Winberg; C S Goodman; M Poo; M Tessier-Lavigne; P M Comoglio
Journal:  Cell       Date:  1999-10-01       Impact factor: 41.582

6.  Plexin-A1 and its interaction with DAP12 in immune responses and bone homeostasis.

Authors:  Noriko Takegahara; Hyota Takamatsu; Toshihiko Toyofuku; Tohru Tsujimura; Tatsusada Okuno; Kazunori Yukawa; Masayuki Mizui; Midori Yamamoto; Durbaka V R Prasad; Kazuhiro Suzuki; Masaru Ishii; Kenta Terai; Masayuki Moriya; Yuji Nakatsuji; Saburo Sakoda; Shintaro Sato; Shizuo Akira; Kiyoshi Takeda; Masanori Inui; Toshiyuki Takai; Masahito Ikawa; Masaru Okabe; Atsushi Kumanogoh; Hitoshi Kikutani
Journal:  Nat Cell Biol       Date:  2006-05-21       Impact factor: 28.824

7.  Polysialylation controls dendritic cell trafficking by regulating chemokine recognition.

Authors:  Eva Kiermaier; Christine Moussion; Christopher T Veldkamp; Rita Gerardy-Schahn; Ingrid de Vries; Larry G Williams; Gary R Chaffee; Andrew J Phillips; Friedrich Freiberger; Richard Imre; Deni Taleski; Richard J Payne; Asolina Braun; Reinhold Förster; Karl Mechtler; Martina Mühlenhoff; Brian F Volkman; Michael Sixt
Journal:  Science       Date:  2015-12-10       Impact factor: 47.728

8.  Galectin-1, a novel ligand of neuropilin-1, activates VEGFR-2 signaling and modulates the migration of vascular endothelial cells.

Authors:  S H Hsieh; N W Ying; M H Wu; W F Chiang; C L Hsu; T Y Wong; Y T Jin; T M Hong; Y L Chen
Journal:  Oncogene       Date:  2008-01-28       Impact factor: 9.867

9.  The cleavage of semaphorin 3C induced by ADAMTS1 promotes cell migration.

Authors:  Cary Esselens; Jordi Malapeira; Núria Colomé; Carmen Casal; Juan Carlos Rodríguez-Manzaneque; Francesc Canals; Joaquín Arribas
Journal:  J Biol Chem       Date:  2009-11-13       Impact factor: 5.157

10.  Chemotaxis of cell populations through confined spaces at single-cell resolution.

Authors:  Ziqiu Tong; Eric M Balzer; Matthew R Dallas; Wei-Chien Hung; Kathleen J Stebe; Konstantinos Konstantopoulos
Journal:  PLoS One       Date:  2012-01-18       Impact factor: 3.240

View more
  15 in total

Review 1.  Neuroimmune semaphorins as costimulatory molecules and beyond.

Authors:  Svetlana P Chapoval
Journal:  Mol Med       Date:  2018-04-04       Impact factor: 6.354

2.  Semaphorin3E/plexinD1 Axis in Asthma: What We Know So Far!

Authors:  Latifa Koussih; Abdelilah S Gounni
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Neuropilin-2 regulates airway inflammatory responses to inhaled lipopolysaccharide.

Authors:  Robert M Immormino; David C Lauzier; Hideki Nakano; Michelle L Hernandez; Neil E Alexis; Andrew J Ghio; Stephen L Tilley; Claire M Doerschuk; David B Peden; Donald N Cook; Timothy P Moran
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-04-19       Impact factor: 5.464

Review 4.  Semaphorin 3A in the Immune System: Twenty Years of Study.

Authors:  Ekaterina P Kiseleva; Kristina V Rutto
Journal:  Biochemistry (Mosc)       Date:  2022-07       Impact factor: 2.824

5.  Integrated single-cell analyses decode the developmental landscape of the human fetal spine.

Authors:  Haiyan Yu; Donge Tang; Hongwei Wu; Chunhong Li; Yongping Lu; Fang He; Xiaogang Zhang; Yane Yang; Wei Shi; Wenlong Hu; Zhipeng Zeng; Weier Dai; Minglin Ou; Yong Dai
Journal:  iScience       Date:  2022-06-27

6.  A Hierarchy of Proliferative and Migratory Keratinocytes Maintains the Tympanic Membrane.

Authors:  Stacey M Frumm; Shengyang Kevin Yu; Joseph Chang; Jordan A Artichoker; Sonia M Scaria; Katharine P Lee; Lauren E Byrnes; Julie B Sneddon; Aaron D Tward
Journal:  Cell Stem Cell       Date:  2020-11-11       Impact factor: 25.269

7.  Semaphorin3A: A Potential Therapeutic Tool for Lupus Nephritis.

Authors:  Jacob Bejar; Ofra Kessler; Adi D Sabag; Edmond Sabo; Ofer Ben Itzhak; Gera Neufeld; Zahava Vadasz
Journal:  Front Immunol       Date:  2018-04-04       Impact factor: 7.561

Review 8.  Multifaceted Role of Neuropilins in the Immune System: Potential Targets for Immunotherapy.

Authors:  Sohini Roy; Arup K Bag; Rakesh K Singh; James E Talmadge; Surinder K Batra; Kaustubh Datta
Journal:  Front Immunol       Date:  2017-10-10       Impact factor: 7.561

Review 9.  Class-3 Semaphorins and Their Receptors: Potent Multifunctional Modulators of Tumor Progression.

Authors:  Shira Toledano; Inbal Nir-Zvi; Rotem Engelman; Ofra Kessler; Gera Neufeld
Journal:  Int J Mol Sci       Date:  2019-01-28       Impact factor: 5.923

Review 10.  Neuropilin-1: A Key Protein to Consider in the Progression of Pediatric Brain Tumors.

Authors:  Manon Douyère; Pascal Chastagner; Cédric Boura
Journal:  Front Oncol       Date:  2021-07-01       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.